Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ)

被引:91
|
作者
Ristow, Oliver [1 ,2 ]
Otto, Sven [3 ]
Troeltzsch, Matthias [3 ]
Hohlweg-Majert, Bettina [2 ,4 ]
Pautke, Christoph [2 ,3 ]
机构
[1] Heidelberg Univ, Dept Oral & Maxillofacial Surg, D-69120 Heidelberg, Germany
[2] Clin Oral & Maxillofacial & Plast Surg, D-80333 Munich, Germany
[3] Univ Munich, Dept Oral & Maxillofacial Surg, D-80336 Munich, Germany
[4] Tech Univ Munich, Dept Oral & Maxillofacial Surg, D-81675 Munich, Germany
关键词
Bisphosphonate; Denosumab; Osteonecrosis of the jaw; BRONJ; Surgical treatment; Fluorescence-guided bone resection; BISPHOSPHONATE-RELATED OSTEONECROSIS; GUIDED BONE RESECTION; RISK-FACTORS; FOLLOW-UP; SURGICAL RESECTION; MULTIPLE-MYELOMA; CANCER-PATIENTS; CASE SERIES; FLUORESCENCE; MANAGEMENT;
D O I
10.1016/j.jcms.2014.11.014
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
The medication-related osteonecrosis of the jaw (MRONJ) is believed to be a therapy-resistant entity. Although the application of the recommended conservative and surgical treatment regimens have returned variable success rates, the increased awareness and experience with MRONJ suggests that surgical therapy can halt the progression of the disease, thereby allowing a histology-based diagnosis of the osteonecrosis. Surgical treatment protocols can achieve success rates of over 90% and novel techniques such as the visualization of bone fluorescence can assist in the intra-operative delineation of the osteonecrosis and standardize the procedure. (C) 2014 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:290 / 293
页数:4
相关论文
共 50 条
  • [31] Surgical strategy for medication-related osteonecrosis of the jaw (MRONJ) on maxilla: A multicenter retrospective study
    Okuyama, Kohei
    Hayashida, Saki
    Rokutanda, Satoshi
    Kawakita, Akiko
    Soutome, Sakiko
    Sawada, Shunsuke
    Yanamoto, Souichi
    Kojima, Yuka
    Umeda, Masahiro
    JOURNAL OF DENTAL SCIENCES, 2021, 16 (03) : 885 - 890
  • [32] A Multidisciplinary Pathway for the Diagnosis and Prosthodontic Management of a Patient with Medication-Related Osteonecrosis of the Jaw (MRONJ)
    Bugshan, Amr S.
    Al-Dulaijan, Yousif A.
    APPLIED SCIENCES-BASEL, 2022, 12 (16):
  • [33] Reporting Criteria for Clinical Trials on Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review and Recommendations
    Gaudet, Camille
    Odet, Stephane
    Meyer, Christophe
    Chatelain, Brice
    Weber, Elise
    Parmentier, Anne-Laure
    Derruau, Stephane
    Laurence, Sebastien
    Mauprivez, Cedric
    Brenet, Esteban
    Kerdjoudj, Halima
    Fenelon, Mathilde
    Fricain, Jean-Christophe
    Zwetyenga, Narcisse
    Hoarau, David
    Curien, Remi
    Gerard, Eric
    Louvrier, Aurelien
    Gindraux, Florelle
    CELLS, 2022, 11 (24)
  • [34] Case series of medication-related osteonecrosis of the jaw (MRONJ) patients prescribed a drug holiday
    Hamid, Aruche
    Thomas, Steven
    Bell, Christopher
    Gormley, Mark
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2023, 61 (03): : 227 - 232
  • [35] Medication-related osteonecrosis of the jaw (MRONJ) systemic review: mevalonate pathway mechanisms explored
    Cho, Jungsuk
    Feldman, George
    Tomlinson, Ryan
    Taub, Dan
    Diecidue, Robert
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2024, 138 (04): : 475 - 483
  • [36] Treatment of medication-related osteonecrosis of the jaw with cell therapy
    Bouland, Cyril Lucien
    Javadian, Rokneddine
    Gilis, Sarah
    Yanni, Antoine
    Le Clercq, Maxime
    Mestrallet, Pierre
    Kampouridis, Stelianos
    Bron, Dominique
    Lalmand, Martin
    Vanden Eynden, Xavier
    Boutremans, Edward
    Dequanter, Didier
    Loeb, Isabelle
    Philippart, Pierre
    Lagneaux, Laurence
    Meuleman, Nathalie
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [37] Prognosis of Medication-Related Osteonecrosis of the Jaw with Surgical Treatment
    Kobayashi, Eizaburo
    Takahashi, Haruka
    Igarashi, Kensuke
    Katagiri, Hiroki
    Haga-Tsujimura, Maiko
    Ogura, Ichiro
    Nakahara, Ken
    Tanaka, Akira
    JOURNAL OF HARD TISSUE BIOLOGY, 2022, 31 (01) : 39 - 46
  • [38] MEDICATION RELATED OSTEONECROSIS OF THE JAW (MRONJ) IN THE TREATMENT OF OSTEOPOROSIS: A CASE SERIES
    Seebah, S.
    Fitzpatrick, D.
    Lalor, P.
    Maher, N.
    O'Carroll, C.
    Steen, G.
    Fallon, N.
    Alemam, M.
    Lannon, R.
    Mc Carroll, K.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S359 - S359
  • [39] Preventing medication-related osteonecrosis of the jaw
    Zebic, Lara
    Patel, Vinod
    BMJ-BRITISH MEDICAL JOURNAL, 2019, 365
  • [40] Fat Graft in Surgical Treatment of Medication-Related Osteonecrosis of the Jaws (MRONJ)
    De Cicco, Davide
    Tartaro, Gianpaolo
    Colella, Giuseppe
    Dell'Aversana Orabona, Giovanni
    Santagata, Mario
    Ferrieri, Ivo
    Troiano, Antonio
    Stagliano, Samuel
    Volgare, Andrea Salvatore
    D'Amato, Salvatore
    APPLIED SCIENCES-BASEL, 2021, 11 (23):